Literature DB >> 26288687

Modulation of the Interaction between a Peptide Ligand and a G Protein-Coupled Receptor by Halogen Atoms.

Mònica Rosa1, Gianluigi Caltabiano2, Katy Barreto-Valer3, Verónica Gonzalez-Nunez3, José C Gómez-Tamayo2, Ana Ardá4, Jesús Jiménez-Barbero4, Leonardo Pardo2, Raquel E Rodríguez3, Gemma Arsequell1, Gregorio Valencia1.   

Abstract

Systematic halogenation of two native opioid peptides has shown that halogen atoms can modulate peptide-receptor interactions in different manners. First, halogens may produce a steric hindrance that reduces the binding of the peptide to the receptor. Second, chlorine, bromine, or iodine may improve peptide binding if their positive σ-hole forms a halogen bond interaction with negatively charged atoms of the protein. Lastly, the negative electrostatic potential of fluorine can interact with positively charged atoms of the protein to improve peptide binding.

Entities:  

Keywords:  G protein-coupled receptors; Halogen bond; Leu-enkephalin; drug design; endomorphin-1; halogenated peptides; neuropeptides; opioid receptors

Year:  2015        PMID: 26288687      PMCID: PMC4538429          DOI: 10.1021/acsmedchemlett.5b00126

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  36 in total

1.  A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin.

Authors:  L K Vaughn; R J Knapp; G Toth; Y P Wan; V J Hruby; H I Yamamura
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

2.  Stereoselective fluorination alters the geometry of a cyclic peptide: exploration of backbone-fluorinated analogues of unguisin A.

Authors:  Xiang-Guo Hu; Donald S Thomas; Renate Griffith; Luke Hunter
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-21       Impact factor: 15.336

3.  Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.

Authors:  T J Abbruscato; S A Williams; A Misicka; A W Lipkowski; V J Hruby; T P Davis
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

4.  Fluorine as a hydrogen-bond acceptor: experimental evidence and computational calculations.

Authors:  Claudio Dalvit; Christian Invernizzi; Anna Vulpetti
Journal:  Chemistry       Date:  2014-07-17       Impact factor: 5.236

5.  Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.

Authors:  Jie Yin; Juan Carlos Mobarec; Peter Kolb; Daniel M Rosenbaum
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

6.  Halogen bonding: the sigma-hole. Proceedings of "Modeling interactions in biomolecules II", Prague, September 5th-9th, 2005.

Authors:  Timothy Clark; Matthias Hennemann; Jane S Murray; Peter Politzer
Journal:  J Mol Model       Date:  2006-08-23       Impact factor: 1.810

7.  Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters.

Authors:  Arnau Cordomí; Gianluigi Caltabiano; Leonardo Pardo
Journal:  J Chem Theory Comput       Date:  2012-02-21       Impact factor: 6.006

8.  Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.

Authors:  K Fukuda; K Terasako; S Kato; K Mori
Journal:  FEBS Lett       Date:  1995-10-09       Impact factor: 4.124

9.  Substitution on the Phe3 aromatic ring in cyclic delta opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity.

Authors:  D L Heyl; H I Mosberg
Journal:  J Med Chem       Date:  1992-05-01       Impact factor: 7.446

10.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more
  2 in total

1.  The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors.

Authors:  Robert J Cassell; Krishna K Sharma; Hongyu Su; Benjamin R Cummins; Haoyue Cui; Kendall L Mores; Arryn T Blaine; Ryan A Altman; Richard M van Rijn
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

2.  Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism.

Authors:  Yeon Sun Lee; Michael Remesic; Cyf Ramos-Colon; Zhijun Wu; Justin LaVigne; Gabriella Molnar; Dagmara Tymecka; Aleksandra Misicka; John M Streicher; Victor J Hruby; Frank Porreca
Journal:  Biomedicines       Date:  2021-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.